RESUMO
A bradykinin B1 receptors antagonist PAV-0056, an 1,4-benzodiazepin-2-one derivative, intragastrically administrated to mice at doses of 0.1 and 1 mg/kg causes analgesia in the "formalin test" not inferior to that of diclofenac sodium (10 mg/kg) and tramadol (20 mg/kg). PAV-0056 at doses of 0.1 and 10 mg/kg has no anxiolytic and central muscle relaxant effects in mice and does not damage the gastric mucosa in rats. Based on the results of the conditioned place preference test, PAV-0056 also does not induce addiction in mice.
Assuntos
Analgésicos , Animais , Camundongos , Ratos , Masculino , Analgésicos/farmacologia , Diclofenaco/farmacologia , Tramadol/farmacologia , Psicotrópicos/farmacologia , Bradicinina/análogos & derivados , Bradicinina/farmacologia , Ansiolíticos/farmacologia , Antagonistas de Receptor B1 da Bradicinina/farmacologia , Ratos Wistar , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Medição da Dor/efeitos dos fármacos , Medição da Dor/métodosRESUMO
We studied the effect of a new indolinone derivative GRS on animal survival and on functioning and histological structure of the lungs in rats with experimental pneumonitis. The rats of experimental groups were intratracheally administered 0.5% aqueous solution of carrageenan under intramuscular anesthesia. Compound GRS (10 mg/kg; a suspension in 0.5% aqueous solution of carboxymethyl cellulose) was orally administered for 4 days starting from the day of carrageenan administration; another rat group received the aqueous solution of carboxymethyl cellulose alone. Control rats received intratracheally isotonic solution of sodium chloride. Animal mortality was registered over 5 days; on day 5, the respiratory parameters were measured, the lungs were weighed, pulmonary edema was evaluated, and histological structure of the lungs was studied. GRS compound improved survival of animals with modeled pneumonitis, restored the respiratory parameters to the level of control animals, and reduced pulmonary edema by 35% and the severity of histological damage score in the lungs by 17% (p<0.05).
RESUMO
We studied the effect of an indolinone derivative GRS on the development of experimental atherosclerosis in C57BL/6 mice. Atherosclerosis was modeled by intraperitoneal administration of endothelial lipoprotein lipase inhibitor Kolliphor P 407 micro Geismar over 5 months. GRS was administered orally in a dose of 10 mg/kg once a day throughout the experiment. In 5 months, the levels of total cholesterol, LDL, and triglycerides in blood serum, as well as histological composition of the ascending aorta were studied. In mice with experimental atherosclerosis, we observed pronounced dyslipidemia with an increase in serum cholesterol, LDL, and triglycerides and accumulation of xanthoma cells in the aorta wall. Repeat administration of GRS did not eliminate dyslipidemia, but prevented an increase in the number of xanthoma cells in the aorta wall (p<0.05). The stimulator of soluble guanylate cyclase GRS did not exhibit hypolipidemic activity, but restored impaired endothelial function in the atherosclerosis model and prevented atherosclerotic damage to blood vessels and vascular wall remodeling.
Assuntos
Aterosclerose , Dislipidemias , Xantomatose , Camundongos , Animais , Guanilil Ciclase Solúvel , LDL-Colesterol , Camundongos Endogâmicos C57BL , Aterosclerose/tratamento farmacológico , Triglicerídeos , Dislipidemias/tratamento farmacológico , Guanilato CiclaseRESUMO
We studied the action of a new indolinone derivative GRS, acetylsalicylic acid (ASA), and their combination on platelet aggregation, vasodilatory endothelial function, neurological status, and cerebral infarction area in experimental focal cerebral ischemia/reperfusion in rats. GRS compound (10 mg/kg), ASA (10 mg/kg), and their combination in the same doses were administered orally once a day as a suspension in 1% starch solution over 5 days after pathology modeling. Sham-operated and control animals were administered 1% starch solution. On day 5 after pathology modeling, platelet aggregation and brain damage area were studied in a half of rats in each group, and the vasodilatory function of the endothelium was studied in the other half. Neurological deficit was assessed 4 h and 1, 3, and 5 days after pathology modeling. GRS compound and ASA equally effectively prevent platelet aggregation and the development of neurological deficit in rats. GRS compound restores the vasodilatory effects of the endothelium, but only ASA contributes to reduction of the cerebral infarction area. In case of combined administration, GRS and ASA do not exhibit synergy in their antiaggregant effect.
Assuntos
Isquemia Encefálica , AVC Isquêmico , Acidente Vascular Cerebral , Ratos , Animais , Inibidores da Agregação Plaquetária/farmacologia , Guanilil Ciclase Solúvel , Aspirina/farmacologia , Agregação Plaquetária , Isquemia Encefálica/tratamento farmacológico , Isquemia Encefálica/patologia , Vasodilatadores/farmacologia , Infarto Cerebral , Amido , Acidente Vascular Cerebral/tratamento farmacológicoRESUMO
New antithrombotic drug GRS, a soluble guanylate cyclase stimulator, after repeated administration in a dose of 10 mg/kg alleviates the symptoms of endothelial dysfunction in rats with myocardial infarction; it restores antiplatelet activity of the blood vessel wall and vasodilatory function of the endothelium without producing significant effect on endothelium-independent vasodilation. GRS also has direct antiaggregant and antihypertensive effects in therapeutic doses. The obtained data suggest that GRS can be therapeutically useful in patients with cardiovascular diseases accompanied by endothelial dysfunction.
Assuntos
Guanilato Ciclase , Infarto do Miocárdio , Animais , Fibrinolíticos/farmacologia , Fibrinolíticos/uso terapêutico , Humanos , Infarto do Miocárdio/tratamento farmacológico , Óxido Nítrico , Ratos , Guanilil Ciclase Solúvel , Vasodilatadores/farmacologiaRESUMO
Effects of the Yantar-Aantitox (succinic acid preparation) preparation on bioenergetic processes in mitochondria of rat liver during the experimental disorders of beta oxidation process evoked by 4-pentenoic acid have been studied. It is established that the course administration of Yantar-Antitox leads to normalization of disturbed bioenergetic processes in rat liver, which is due to stimulation of the rapid metabolic cluster of mitochondria.
Assuntos
Metabolismo Energético/efeitos dos fármacos , Hepatopatias/tratamento farmacológico , Fígado/efeitos dos fármacos , Mitocôndrias Hepáticas/efeitos dos fármacos , Ácido Succínico/administração & dosagem , Animais , Ácidos Graxos Monoinsaturados/efeitos adversos , Fígado/metabolismo , Hepatopatias/metabolismo , Masculino , Mitocôndrias Hepáticas/metabolismo , RatosRESUMO
Treatment of mice by a combination of succinic and glutamic acids prevented the metabolic disorders in the liver under conditions of normobaric hypoxia. In addition, the activity of the mitochondrial fast metabolic cluster remained intact and lipid peroxidation was limited.
Assuntos
Metabolismo Energético/efeitos dos fármacos , Ácido Glutâmico/farmacologia , Hipóxia/fisiopatologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Ácido Succínico/farmacologia , Animais , Combinação de Medicamentos , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/metabolismoRESUMO
In the tests on rats with a model of encephalopathy caused by 4-pentenoic acid (inhibitor of the beta-oxidation of fatty acids), the hepatoprotective agent silymarin increases the respiratory activity in brain mitochondria, improves oxidative phosphorylation coupling and energization, and inhibits lipid peroxidation. Succinic acid (a regulator of bioenergetics) improves the damaged Krebs cycle metabolic pathways and produces an antioxidant effect. The combined use of silymarin and succinic demonstrated more expressed cerebroprotective action as compared to that of each agent administered separately.
Assuntos
Antioxidantes/farmacologia , Encéfalo/efeitos dos fármacos , Metabolismo Energético , Ácidos Graxos/metabolismo , Encefalopatia Hepática/metabolismo , Fármacos Neuroprotetores/farmacologia , Silimarina/farmacologia , Ácido Succínico/uso terapêutico , Animais , Encéfalo/metabolismo , Sinergismo Farmacológico , Ácidos Graxos Monoinsaturados , Encefalopatia Hepática/induzido quimicamente , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Oxirredução , Fosforilação Oxidativa , RatosRESUMO
The dependence of the pharmacokinetic profiles (PhP) of captopril in the phase of adaptation reactions in the organism has been studied within the framework of randomized, comparative, double cross research of bioeqivalency of captopril (Aspharma Co, Anzhero-Sudzhensk) and capoten (Bristol Myers Squibb Co.; official Russian producer, Akrikhin KhimFarmKombinat). It is established that the maximum bioaccessibility and high concentration of captopril in the blood plasma is determined on the background of physiologically optimum reactions of training and in the zone of quiet activation. These characteristics decrease during the reactions of general adaptation syndrome according to the type of increased activation and reactivation.
Assuntos
Adaptação Fisiológica , Inibidores da Enzima Conversora de Angiotensina/farmacocinética , Anti-Hipertensivos/farmacocinética , Captopril/farmacocinética , Síndrome de Adaptação Geral/metabolismo , Adulto , Disponibilidade Biológica , Feminino , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Rat brain mitochondria were isolated and their respiration was polarographically measured without contact with air oxygen. Gas-saturated experimental mixtures close to the in vivo partial oxygen pressure (normoxic) were compared with the air-saturated, i.e. hyperoxic, mixtures. The rate of phosphorylating oxidation of added succinate under normoxic conditions was found to be 70-100% higher compared with hyperoxic ones. The addition of succinate dehydrogenase activators results in a more than two-fold stronger stimulation of succinate oxidation under normoxia than under hyperoxia. Thiol group donors are shown to stimulate respiration under hyperoxia and not under normoxia. Hyperoxic conditions prevented oxidation of the low succinate concentrations corresponding to the physiological ones.
Assuntos
Mitocôndrias/metabolismo , Oxigênio/metabolismo , Succinatos/metabolismo , Ar , Animais , Cinética , Masculino , Oxirredução , Fosforilação , Ratos , Succinato Desidrogenase/metabolismo , Ácido SuccínicoRESUMO
Oxidative phosphorylation in the mitochondria of rat brain in normobaric hypercapnic hypoxia and preventive administration of Scutellaria baicalensis extract was studied by polarography. Hypoxia causes diminution of energy of the rat brain mitochondria with separation of oxidative phosphorylation and inhibition of the reactions of rapid metabolic cluster of Krebs' cycle. Scutellaria baicalensis extract prevents diminution of energy of the brain mitochondria in hypoxia, inhibits restriction of succinate dependent energy production, and preserves intactness of the mitochondrial membranes.
Assuntos
Encéfalo/efeitos dos fármacos , Hipóxia/enzimologia , Mitocôndrias/efeitos dos fármacos , Extratos Vegetais/farmacologia , Ácido Succínico/metabolismo , Animais , Encéfalo/enzimologia , Química Encefálica/efeitos dos fármacos , Hipercapnia/enzimologia , Masculino , Mitocôndrias/enzimologia , Oxirredução/efeitos dos fármacos , Fosforilação Oxidativa/efeitos dos fármacos , Ratos , Fatores de TempoRESUMO
A mixture of mitochondrial substrates of succinic and malic acids more effectively than antihypoxant trimetazidine prevented functional and metabolic disorders in rat myocardium during acute ischemia: reduces T wave amplitude, QT interval, number and duration of arrhythmias, and restores oxidation-phosphorylation coupling.
Assuntos
Cardiotônicos/uso terapêutico , Malatos/uso terapêutico , Isquemia Miocárdica/tratamento farmacológico , Ácido Succínico/uso terapêutico , Trimetazidina/uso terapêutico , Vasodilatadores/uso terapêutico , Animais , Antiarrítmicos/uso terapêutico , Arritmias Cardíacas/tratamento farmacológico , Oclusão Coronária/fisiopatologia , Combinação de Medicamentos , Eletrocardiografia , Coração/efeitos dos fármacos , Coração/fisiopatologia , Masculino , Mitocôndrias Cardíacas/efeitos dos fármacos , Mitocôndrias Cardíacas/metabolismo , Isquemia Miocárdica/fisiopatologia , Fosforilação Oxidativa/efeitos dos fármacos , Ratos , Ratos Wistar , Taquicardia/tratamento farmacológicoRESUMO
Cerebronorm prevents de-energization of mitochondria, limitation of succinate- and NAD-dependent energy production, and oxidation-phosphorylation uncoupling and inhibits LPO processes in the brain of rats under conditions of hypoxia.
Assuntos
Encéfalo/metabolismo , Metabolismo Energético/fisiologia , Hipóxia/fisiopatologia , Peroxidação de Lipídeos/fisiologia , Animais , Encéfalo/efeitos dos fármacos , Metabolismo Energético/efeitos dos fármacos , Inosina Difosfato/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/metabolismo , Niacinamida/farmacologia , Fosforilação Oxidativa/efeitos dos fármacos , Ratos , Riboflavina/farmacologia , Ácido Succínico/farmacologiaRESUMO
In rats with experimental encephalopathy caused by intoxication with 4-pentenoic acid inhibiting beta-oxidation of medium- and long-chain fatty acids, hepatoprotector silimarin inhibited LPO, prevented deenergization and maintained high respiratory activity of brain mitochondria, and increased the rate and coupling of oxidation and phosphorylation. Succinic acid improved oxidation of substrates in motochondria and promoted activation of succinate-dependent ATP generation. Silimarin and succinic acid used together produced a synergistic protective effect on brain mitochondria surpassing the protective effects of individual preparations and prevented LPO activation.
Assuntos
Encefalopatias/metabolismo , Silimarina/farmacologia , Ácido Succínico/farmacologia , Animais , Encefalopatias/induzido quimicamente , Combinação de Medicamentos , Metabolismo Energético/efeitos dos fármacos , Ácidos Graxos/metabolismo , Ácidos Graxos Monoinsaturados , Masculino , Fosforilação Oxidativa/efeitos dos fármacos , Ratos , Silimarina/administração & dosagem , Ácido Succínico/administração & dosagemRESUMO
Silymarin (70 mg/kg) and succinic acid (50 mg/kg) reduce blood glucose and cholesterol concentrations, inhibit LPO, and correct oxidative phosphorylation disturbances in liver mitochondria in experimental diabetes mellitus induced by injection of streptozotocin (65 mg/kg) in rats.
Assuntos
Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/metabolismo , Mitocôndrias Hepáticas/metabolismo , Silimarina/uso terapêutico , Ácido Succínico/uso terapêutico , Animais , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Colesterol/sangue , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Camundongos , Mitocôndrias Hepáticas/efeitos dos fármacos , Doenças Mitocondriais/tratamento farmacológico , Fosforilação Oxidativa/efeitos dos fármacosRESUMO
Energy metabolism regulator Amber-anti-tox had a systemic effect under experimental conditions of vibration-induced dysregulation. Whole-body vibration was accompanied by nonlinear changes in energy metabolism in the heart, liver, kidneys, and lymphocytes and impairment of intra-systemic inter-organ relationships between mitochondria. Amber-anti-tox prevented vibration-induced de-energization of mitochondria and contributed to the preservation of multidimensional relationships of energy metabolism in vital internal organs.
Assuntos
Metabolismo Energético , Animais , Antitoxinas/farmacologia , Análise Fatorial , Rim/metabolismo , Fígado/metabolismo , Linfócitos/metabolismo , Masculino , Miocárdio/metabolismo , Coelhos , VibraçãoRESUMO
Mitochondrial substrate-based preparations corrected disorders, caused by long-term exposure to abnormal gravitation vector in head-down tilt (hanging) test in rats. The preparations produced systemic and polyorgan protective effects consisting in correction of the blood prooxidant/antioxidant balance, energy metabolism in musculus soleus, and minimization of morphological changes in the liver and kidneys.
Assuntos
Metabolismo Energético , Gravitação , Decúbito Inclinado com Rebaixamento da Cabeça , Mitocôndrias/metabolismo , Animais , Antioxidantes/metabolismo , Metabolismo Energético/efeitos dos fármacos , Malatos/farmacologia , Masculino , Oxidantes/sangue , Ratos , Ratos Wistar , Ácido Succínico/farmacologiaRESUMO
Phenobarbital and Benzonal in anticonvulsive doses depress energy production by brain mitochondria of rats, with phenobarbital inhibiting NAD-dependent respiration and Benzonal oxidation of succinate.
Assuntos
Anticonvulsivantes/farmacologia , Barbitúricos/farmacologia , Encéfalo/efeitos dos fármacos , Ácidos Cetoglutáricos/metabolismo , Mitocôndrias/efeitos dos fármacos , Fenobarbital/farmacologia , Succinatos/metabolismo , Ácido 3-Hidroxibutírico , Animais , Encéfalo/enzimologia , Hidroxibutiratos/metabolismo , Técnicas In Vitro , Masculino , Mitocôndrias/enzimologia , NAD/metabolismo , Oxirredução/efeitos dos fármacos , Consumo de Oxigênio/efeitos dos fármacos , Ratos , Succinato Desidrogenase/metabolismo , Ácido SuccínicoRESUMO
Corasole-induced convulsive fits are accompanied by the activation of succinate oxidation in the isolated mitochondria, paralleled by the mounting effect of factors limiting succinate dehydrogenase activity. Diverse seasonal sensitivity to corasole correlates with the inhibition of succinate-dependent energy supply for the functional neuronal activity.
Assuntos
Encéfalo/metabolismo , Mitocôndrias/metabolismo , Convulsões/metabolismo , Succinatos/metabolismo , Animais , Masculino , Oxirredução , Pentilenotetrazol/toxicidade , Ratos , Ratos Endogâmicos , Estações do Ano , Convulsões/induzido quimicamenteRESUMO
The authors discovered antihypoxic properties of the bemitil (pretreatment injections 50 mg/kg intraperitoneally) in the experiments on rats with the circulatory or hypoxic hypoxia. There was limitation of pO decrease and diene conjugates and Schiff bases production increase with the drug in the circulatory hypoxia conditions. Bemitil restricted malondialdehyde accumulation in the rat brain homogenate under the activation of free radicals processes. In the mitochondrial suspension incubation similar effect of the medicine was accompanied with limitation of organelle degradation. Bemitil showed no antiradical activity.